Healthcare Professional Check

This website is intended for diabetes healthcare professionals. Click one of the options below to access the content.

You are here

Latest Results on Switching Type 2 Diabetes Patients From Insulin Glargine to Insulin Degludec


Insulin Educational Programme: B4 Cos


Professor Cos, Catalonian Health Institute and Autonomous University of Barcelona, discusses results and clinical implications of the latest crossover trial in patients with type 2 diabetes switched from glargine to degludec, which was presented at the recent 76th scientific session of the American Diabetes Association 2016 in New Orleans, US, June 10-14.


Download slides